Shares of Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD -0.06% inched 0.01% higher to $70.45 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.37% falling 0.57% to 4,443.05 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% falling 0.84% to 34,577.57. The stock's fall snapped a two-day winning streak. Gilead Sciences Inc. closed $2.89 short of its 52-week high ($73.34), which the company reached on August 18th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.05% fell 0.60% to $164.80, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.99% fell 0.58% to $72.11, and AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.89% fell 0.93% to $106.48. Trading volume (5.5 M) remained 495,234 below its 50-day average volume of 6.0 M.